Clearmind Medicine Inc.CMNDNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank81
5Y CAGR+12.9%
Year-over-Year Change
Year-over-year earnings per share growth rate
5Y CAGR
+12.9%/yr
Long-term compound
Percentile
P81
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 50.77% |
| Q3 2025 | -57.56% |
| Q2 2025 | 38.88% |
| Q1 2025 | -21.82% |
| Q4 2024 | 64.64% |
| Q3 2024 | -114.02% |
| Q2 2024 | 68.51% |
| Q1 2024 | 92.30% |
| Q4 2023 | -389.19% |
| Q3 2023 | 85.81% |
| Q2 2023 | 31.61% |
| Q1 2023 | 32.75% |
| Q4 2022 | -7.36% |
| Q3 2022 | 37.76% |
| Q2 2022 | -46.59% |
| Q1 2022 | 15.72% |
| Q4 2021 | -92.83% |
| Q3 2021 | -259.16% |
| Q2 2021 | -87.82% |
| Q1 2021 | -29.79% |
| Q4 2020 | 27.66% |
| Q3 2020 | -33.94% |
| Q2 2020 | -80.18% |
| Q1 2020 | -0.66% |
| Q4 2019 | -15.34% |
| Q3 2019 | 41.47% |
| Q2 2019 | -67.54% |
| Q1 2019 | 84.53% |
| Q4 2018 | -635.72% |
| Q3 2018 | -282.84% |
| Q2 2018 | 82.68% |
| Q1 2018 | -336.20% |
| Q4 2017 | 0.00% |